| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 67.05▼ | 66.95▲ | 66.93▲ | 66.54▲ | 66.90▲ |
| MA10 | 67.06▼ | 66.86▲ | 66.93▲ | 66.84▲ | 67.02▼ |
| MA20 | 67.04▼ | 66.94▲ | 66.74▲ | 66.27▲ | 69.61▼ |
| MA50 | 66.88▲ | 66.68▲ | 66.91▲ | 67.58▼ | 74.33▼ |
| MA100 | 66.92▲ | 66.99▲ | 66.54▲ | 70.36▼ | 76.22▼ |
| MA200 | 66.77▲ | 66.46▲ | 66.12▲ | 73.51▼ | 77.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | 0.009▲ | 0.040▲ | 0.188▲ | -0.070▼ |
| RSI | 54.067▲ | 54.682▲ | 54.833▲ | 51.944▲ | 39.737▼ |
| STOCH | 40.555 | 63.953 | 51.419 | 50.121 | 30.574 |
| WILL %R | -68.182 | -36.047 | -25.287 | -26.842 | -69.260 |
| CCI | -111.652▼ | 77.949 | 54.632 | 36.097 | -50.873 |
| ▲ RSI&VOL | $DLB RSI Cross Up and Volume | Set Alert |
| RSI | $DLB RSI(14) Crossed Above 50 | Set Alert |
| MA | $DLB Price Crossed Above MA(13) | Set Alert |
| MA | $DLB Price Crossed Above MA(7) | Set Alert |
| CDL | $DLB Three-Line Strike Candlestick Pattern Detected | Set Alert |
| CDL | $DLB Engulfing Candlestick Pattern Detected | Set Alert |
|
Thursday, December 04, 2025 02:15 PM
Phase 2b trial showed significant improvements on primary and key secondary outcomes measures, most prominently in patients without AD co-pathology Significant reduction in key neurodegeneration ...
|
|
Thursday, December 04, 2025 02:12 PM
Key findings showed neflamapimod reduced clinical worsening by 52% on the primary endpoint, Clinical Dementia Rating Sum of Boxes (CDR-SB), compared to control at 16 weeks. This effect was even more ...
|
|
Wednesday, December 03, 2025 04:48 AM
Scheduled for Second Half of January -PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/12/25 | 66.89 | 67.19 | 66.47 | 67.02 | 357,377 |
| 05/12/25 | 65.99 | 67.36 | 65.90 | 67.00 | 662,500 |
| 04/12/25 | 66.46 | 66.86 | 65.90 | 66.07 | 561,000 |
| 03/12/25 | 66.32 | 67.285 | 66.20 | 66.29 | 538,508 |
| 02/12/25 | 66.87 | 67.29 | 66.09 | 66.31 | 523,000 |
| 01/12/25 | 67.18 | 68.00 | 66.99 | 67.14 | 637,004 |
| 28/11/25 | 66.80 | 68.12 | 66.80 | 67.45 | 286,215 |
| 26/11/25 | 67.21 | 67.75 | 66.97 | 67.00 | 601,931 |
| 25/11/25 | 66.70 | 68.00 | 66.51 | 67.38 | 523,859 |
| 24/11/25 | 67.37 | 67.37 | 66.49 | 66.77 | 899,562 |
|
|
||||
|
|
||||
|
|